Loading…

Nodal Low-Grade B-Cell Lymphoma Co-Expressing CD5 and CD10 but Not CD23, IRTA1, or Cyclin D1: The Diagnostic Challenge of a Splenic Marginal Zone Lymphoma

The diagnosis of lymphoma is based on histopathological and immunophenotypical features. CD5 and CD10 are traditionally considered a T-cell antigen and a germinal center B-cell antigen, respectively. It is very unusual for a low-grade B-cell lymphoma (BCL) to co-express CD5 and CD10. Although the bi...

Full description

Saved in:
Bibliographic Details
Published in:Diagnostics (Basel) 2024-03, Vol.14 (6), p.640
Main Authors: Win, Khin-Than, Hsieh, Yen-Chuan, Wu, Hung-Chang, Chuang, Shih-Sung
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c567t-956539f7131fa804c9dd8e216fa406a39068f260eab9468a406752c80106089a3
cites cdi_FETCH-LOGICAL-c567t-956539f7131fa804c9dd8e216fa406a39068f260eab9468a406752c80106089a3
container_end_page
container_issue 6
container_start_page 640
container_title Diagnostics (Basel)
container_volume 14
creator Win, Khin-Than
Hsieh, Yen-Chuan
Wu, Hung-Chang
Chuang, Shih-Sung
description The diagnosis of lymphoma is based on histopathological and immunophenotypical features. CD5 and CD10 are traditionally considered a T-cell antigen and a germinal center B-cell antigen, respectively. It is very unusual for a low-grade B-cell lymphoma (BCL) to co-express CD5 and CD10. Although the biologic basis or clinical significance of such co-expression is unclear, this rare event may pose a significant diagnostic challenge. Here, we report a case of a 63-year-old male presenting with bilateral cervical lymphadenopathy and lymphocytosis. Histologically, the nodal tumor was largely diffuse with neoplastic small atypical lymphocytes co-expressing CD5, CD10, and CD20, but not CD23 or cyclin D1. The leukemic cells in the peripheral blood exhibited hairy projections. Taking together the marked splenomegaly, involvement of lymph nodes, bone marrow, and peripheral blood, a final diagnosis of splenic marginal zone lymphoma (SMZL) was reached. The patient was alive with partial response for 10 months after immunochemotherapy. The dual expression of CD5 and CD10 is extremely unusual for low-grade BCL and may lead to an erroneous diagnosis. Integrating the findings into peripheral blood smear tests, flow cytometry, histopathology, imaging, and clinical features is mandatory to exclude other lymphoma types and to reach a correct diagnosis, particularly for a case with nodal presentation.
doi_str_mv 10.3390/diagnostics14060640
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_8afc131a772c4a29a076babc40b54b39</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A788245856</galeid><doaj_id>oai_doaj_org_article_8afc131a772c4a29a076babc40b54b39</doaj_id><sourcerecordid>A788245856</sourcerecordid><originalsourceid>FETCH-LOGICAL-c567t-956539f7131fa804c9dd8e216fa406a39068f260eab9468a406752c80106089a3</originalsourceid><addsrcrecordid>eNptUsGO0zAQjRCIXS37BUjIEhcOm8WO48Thgkq6LJXKIkG5cLEmjpO6SuKunQL9Fb6WKV3KFm1ycPzy5s3Mm4mi54xecl7Q17WFdnBhtDqwlGY0S-mj6DShuYjTlMnH975PovMQVhSfgnGZiKfRCZeCC4w6jX7duBo6Mnc_4msPtSHv4tJ0CGz79dL1QEoXX_1cexOCHVpSTgWBocaTUVJtRnLjRrwk_ILMPi8m7II4T8qt7uxApuwNWSwNmR5KJeUSus4MrSGuIUC-rPGC8EfwrR2wjG9uMIfUz6InDXTBnN-dZ9HX91eL8kM8_3Q9KyfzWIssH-NCZIIXTc44a0DSVBd1LU3CsgbQGECzMtkkGTVQFWkmd2AuEi0pQwNkAfwsmu11awcrtfa2B79VDqz6AzjfKvBYfWeUhEZjHsjzRKeQFEDzrIJKp7QSacUL1Hq711pvqt7U2gyjh-5I9PjPYJeqdd8Vo0VW0ISiwqs7Be9uNyaMqrdB40hgMG4TFKeUpzxNpETqy_-oK7fx6GNQSYGzznaN_mO1gB3YoXGYWO9E1SSXMkmFFBmyLh9g4Vub3mocS2MRPwrg-wDtXQjeNIcmGVW7FVUPrChGvbjvzyHm70Ly3_6a3tA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2991366752</pqid></control><display><type>article</type><title>Nodal Low-Grade B-Cell Lymphoma Co-Expressing CD5 and CD10 but Not CD23, IRTA1, or Cyclin D1: The Diagnostic Challenge of a Splenic Marginal Zone Lymphoma</title><source>PubMed (Medline)</source><source>Publicly Available Content Database</source><creator>Win, Khin-Than ; Hsieh, Yen-Chuan ; Wu, Hung-Chang ; Chuang, Shih-Sung</creator><creatorcontrib>Win, Khin-Than ; Hsieh, Yen-Chuan ; Wu, Hung-Chang ; Chuang, Shih-Sung</creatorcontrib><description>The diagnosis of lymphoma is based on histopathological and immunophenotypical features. CD5 and CD10 are traditionally considered a T-cell antigen and a germinal center B-cell antigen, respectively. It is very unusual for a low-grade B-cell lymphoma (BCL) to co-express CD5 and CD10. Although the biologic basis or clinical significance of such co-expression is unclear, this rare event may pose a significant diagnostic challenge. Here, we report a case of a 63-year-old male presenting with bilateral cervical lymphadenopathy and lymphocytosis. Histologically, the nodal tumor was largely diffuse with neoplastic small atypical lymphocytes co-expressing CD5, CD10, and CD20, but not CD23 or cyclin D1. The leukemic cells in the peripheral blood exhibited hairy projections. Taking together the marked splenomegaly, involvement of lymph nodes, bone marrow, and peripheral blood, a final diagnosis of splenic marginal zone lymphoma (SMZL) was reached. The patient was alive with partial response for 10 months after immunochemotherapy. The dual expression of CD5 and CD10 is extremely unusual for low-grade BCL and may lead to an erroneous diagnosis. Integrating the findings into peripheral blood smear tests, flow cytometry, histopathology, imaging, and clinical features is mandatory to exclude other lymphoma types and to reach a correct diagnosis, particularly for a case with nodal presentation.</description><identifier>ISSN: 2075-4418</identifier><identifier>EISSN: 2075-4418</identifier><identifier>DOI: 10.3390/diagnostics14060640</identifier><identifier>PMID: 38535060</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Abdomen ; Antigens ; B cells ; Bendamustine ; Bone marrow ; CD10 ; CD5 ; Flow cytometry ; Genotype &amp; phenotype ; Histopathology ; Immunoglobulin E ; Interesting Images ; Leukemia ; Lymphatic system ; Lymphocytes ; Lymphoma ; marginal zone lymphoma ; Medical imaging ; Non-Hodgkin's lymphomas ; phenotypic aberrancy ; splenic marginal zone lymphoma ; T cells ; villous lymphocyte ; Vincristine</subject><ispartof>Diagnostics (Basel), 2024-03, Vol.14 (6), p.640</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><rights>2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2024 by the authors. 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c567t-956539f7131fa804c9dd8e216fa406a39068f260eab9468a406752c80106089a3</citedby><cites>FETCH-LOGICAL-c567t-956539f7131fa804c9dd8e216fa406a39068f260eab9468a406752c80106089a3</cites><orcidid>0000-0003-3971-525X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2991366752/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2991366752?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25733,27903,27904,36991,36992,44569,53769,53771,74872</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38535060$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Win, Khin-Than</creatorcontrib><creatorcontrib>Hsieh, Yen-Chuan</creatorcontrib><creatorcontrib>Wu, Hung-Chang</creatorcontrib><creatorcontrib>Chuang, Shih-Sung</creatorcontrib><title>Nodal Low-Grade B-Cell Lymphoma Co-Expressing CD5 and CD10 but Not CD23, IRTA1, or Cyclin D1: The Diagnostic Challenge of a Splenic Marginal Zone Lymphoma</title><title>Diagnostics (Basel)</title><addtitle>Diagnostics (Basel)</addtitle><description>The diagnosis of lymphoma is based on histopathological and immunophenotypical features. CD5 and CD10 are traditionally considered a T-cell antigen and a germinal center B-cell antigen, respectively. It is very unusual for a low-grade B-cell lymphoma (BCL) to co-express CD5 and CD10. Although the biologic basis or clinical significance of such co-expression is unclear, this rare event may pose a significant diagnostic challenge. Here, we report a case of a 63-year-old male presenting with bilateral cervical lymphadenopathy and lymphocytosis. Histologically, the nodal tumor was largely diffuse with neoplastic small atypical lymphocytes co-expressing CD5, CD10, and CD20, but not CD23 or cyclin D1. The leukemic cells in the peripheral blood exhibited hairy projections. Taking together the marked splenomegaly, involvement of lymph nodes, bone marrow, and peripheral blood, a final diagnosis of splenic marginal zone lymphoma (SMZL) was reached. The patient was alive with partial response for 10 months after immunochemotherapy. The dual expression of CD5 and CD10 is extremely unusual for low-grade BCL and may lead to an erroneous diagnosis. Integrating the findings into peripheral blood smear tests, flow cytometry, histopathology, imaging, and clinical features is mandatory to exclude other lymphoma types and to reach a correct diagnosis, particularly for a case with nodal presentation.</description><subject>Abdomen</subject><subject>Antigens</subject><subject>B cells</subject><subject>Bendamustine</subject><subject>Bone marrow</subject><subject>CD10</subject><subject>CD5</subject><subject>Flow cytometry</subject><subject>Genotype &amp; phenotype</subject><subject>Histopathology</subject><subject>Immunoglobulin E</subject><subject>Interesting Images</subject><subject>Leukemia</subject><subject>Lymphatic system</subject><subject>Lymphocytes</subject><subject>Lymphoma</subject><subject>marginal zone lymphoma</subject><subject>Medical imaging</subject><subject>Non-Hodgkin's lymphomas</subject><subject>phenotypic aberrancy</subject><subject>splenic marginal zone lymphoma</subject><subject>T cells</subject><subject>villous lymphocyte</subject><subject>Vincristine</subject><issn>2075-4418</issn><issn>2075-4418</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUsGO0zAQjRCIXS37BUjIEhcOm8WO48Thgkq6LJXKIkG5cLEmjpO6SuKunQL9Fb6WKV3KFm1ycPzy5s3Mm4mi54xecl7Q17WFdnBhtDqwlGY0S-mj6DShuYjTlMnH975PovMQVhSfgnGZiKfRCZeCC4w6jX7duBo6Mnc_4msPtSHv4tJ0CGz79dL1QEoXX_1cexOCHVpSTgWBocaTUVJtRnLjRrwk_ILMPi8m7II4T8qt7uxApuwNWSwNmR5KJeUSus4MrSGuIUC-rPGC8EfwrR2wjG9uMIfUz6InDXTBnN-dZ9HX91eL8kM8_3Q9KyfzWIssH-NCZIIXTc44a0DSVBd1LU3CsgbQGECzMtkkGTVQFWkmd2AuEi0pQwNkAfwsmu11awcrtfa2B79VDqz6AzjfKvBYfWeUhEZjHsjzRKeQFEDzrIJKp7QSacUL1Hq711pvqt7U2gyjh-5I9PjPYJeqdd8Vo0VW0ISiwqs7Be9uNyaMqrdB40hgMG4TFKeUpzxNpETqy_-oK7fx6GNQSYGzznaN_mO1gB3YoXGYWO9E1SSXMkmFFBmyLh9g4Vub3mocS2MRPwrg-wDtXQjeNIcmGVW7FVUPrChGvbjvzyHm70Ly3_6a3tA</recordid><startdate>20240301</startdate><enddate>20240301</enddate><creator>Win, Khin-Than</creator><creator>Hsieh, Yen-Chuan</creator><creator>Wu, Hung-Chang</creator><creator>Chuang, Shih-Sung</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-3971-525X</orcidid></search><sort><creationdate>20240301</creationdate><title>Nodal Low-Grade B-Cell Lymphoma Co-Expressing CD5 and CD10 but Not CD23, IRTA1, or Cyclin D1: The Diagnostic Challenge of a Splenic Marginal Zone Lymphoma</title><author>Win, Khin-Than ; Hsieh, Yen-Chuan ; Wu, Hung-Chang ; Chuang, Shih-Sung</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c567t-956539f7131fa804c9dd8e216fa406a39068f260eab9468a406752c80106089a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Abdomen</topic><topic>Antigens</topic><topic>B cells</topic><topic>Bendamustine</topic><topic>Bone marrow</topic><topic>CD10</topic><topic>CD5</topic><topic>Flow cytometry</topic><topic>Genotype &amp; phenotype</topic><topic>Histopathology</topic><topic>Immunoglobulin E</topic><topic>Interesting Images</topic><topic>Leukemia</topic><topic>Lymphatic system</topic><topic>Lymphocytes</topic><topic>Lymphoma</topic><topic>marginal zone lymphoma</topic><topic>Medical imaging</topic><topic>Non-Hodgkin's lymphomas</topic><topic>phenotypic aberrancy</topic><topic>splenic marginal zone lymphoma</topic><topic>T cells</topic><topic>villous lymphocyte</topic><topic>Vincristine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Win, Khin-Than</creatorcontrib><creatorcontrib>Hsieh, Yen-Chuan</creatorcontrib><creatorcontrib>Wu, Hung-Chang</creatorcontrib><creatorcontrib>Chuang, Shih-Sung</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Diagnostics (Basel)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Win, Khin-Than</au><au>Hsieh, Yen-Chuan</au><au>Wu, Hung-Chang</au><au>Chuang, Shih-Sung</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nodal Low-Grade B-Cell Lymphoma Co-Expressing CD5 and CD10 but Not CD23, IRTA1, or Cyclin D1: The Diagnostic Challenge of a Splenic Marginal Zone Lymphoma</atitle><jtitle>Diagnostics (Basel)</jtitle><addtitle>Diagnostics (Basel)</addtitle><date>2024-03-01</date><risdate>2024</risdate><volume>14</volume><issue>6</issue><spage>640</spage><pages>640-</pages><issn>2075-4418</issn><eissn>2075-4418</eissn><abstract>The diagnosis of lymphoma is based on histopathological and immunophenotypical features. CD5 and CD10 are traditionally considered a T-cell antigen and a germinal center B-cell antigen, respectively. It is very unusual for a low-grade B-cell lymphoma (BCL) to co-express CD5 and CD10. Although the biologic basis or clinical significance of such co-expression is unclear, this rare event may pose a significant diagnostic challenge. Here, we report a case of a 63-year-old male presenting with bilateral cervical lymphadenopathy and lymphocytosis. Histologically, the nodal tumor was largely diffuse with neoplastic small atypical lymphocytes co-expressing CD5, CD10, and CD20, but not CD23 or cyclin D1. The leukemic cells in the peripheral blood exhibited hairy projections. Taking together the marked splenomegaly, involvement of lymph nodes, bone marrow, and peripheral blood, a final diagnosis of splenic marginal zone lymphoma (SMZL) was reached. The patient was alive with partial response for 10 months after immunochemotherapy. The dual expression of CD5 and CD10 is extremely unusual for low-grade BCL and may lead to an erroneous diagnosis. Integrating the findings into peripheral blood smear tests, flow cytometry, histopathology, imaging, and clinical features is mandatory to exclude other lymphoma types and to reach a correct diagnosis, particularly for a case with nodal presentation.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>38535060</pmid><doi>10.3390/diagnostics14060640</doi><orcidid>https://orcid.org/0000-0003-3971-525X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2075-4418
ispartof Diagnostics (Basel), 2024-03, Vol.14 (6), p.640
issn 2075-4418
2075-4418
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_8afc131a772c4a29a076babc40b54b39
source PubMed (Medline); Publicly Available Content Database
subjects Abdomen
Antigens
B cells
Bendamustine
Bone marrow
CD10
CD5
Flow cytometry
Genotype & phenotype
Histopathology
Immunoglobulin E
Interesting Images
Leukemia
Lymphatic system
Lymphocytes
Lymphoma
marginal zone lymphoma
Medical imaging
Non-Hodgkin's lymphomas
phenotypic aberrancy
splenic marginal zone lymphoma
T cells
villous lymphocyte
Vincristine
title Nodal Low-Grade B-Cell Lymphoma Co-Expressing CD5 and CD10 but Not CD23, IRTA1, or Cyclin D1: The Diagnostic Challenge of a Splenic Marginal Zone Lymphoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T16%3A01%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nodal%20Low-Grade%20B-Cell%20Lymphoma%20Co-Expressing%20CD5%20and%20CD10%20but%20Not%20CD23,%20IRTA1,%20or%20Cyclin%20D1:%20The%20Diagnostic%20Challenge%20of%20a%20Splenic%20Marginal%20Zone%20Lymphoma&rft.jtitle=Diagnostics%20(Basel)&rft.au=Win,%20Khin-Than&rft.date=2024-03-01&rft.volume=14&rft.issue=6&rft.spage=640&rft.pages=640-&rft.issn=2075-4418&rft.eissn=2075-4418&rft_id=info:doi/10.3390/diagnostics14060640&rft_dat=%3Cgale_doaj_%3EA788245856%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c567t-956539f7131fa804c9dd8e216fa406a39068f260eab9468a406752c80106089a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2991366752&rft_id=info:pmid/38535060&rft_galeid=A788245856&rfr_iscdi=true